Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients
Clinical trial NCT01941316 · COMPLETED
Trial details
- NCT number
- NCT01941316
- Sponsor
- Cancer Research and Biostatistics Clinical Trials Consortium
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2018-12-31
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.